Improving the use of heart and kidney medications in veterans with kidney disease
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
This study is looking at how to better help veterans with chronic kidney disease get the heart medications they need, by figuring out why some aren’t receiving them and creating tools for doctors to make it easier to start or restart these treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michael E Debakey VA Medical Center NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11175239 on NIH RePORTER |
What this research studies
This research investigates how to optimize the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) among veterans suffering from chronic kidney disease (CKD). It aims to identify why a significant number of veterans are not receiving these essential medications, focusing on factors such as side effects and clinical inertia. By analyzing structured datasets and provider notes, the study will develop a communication aid to help healthcare teams initiate or resume ACEI/ARB therapy in CKD patients. The goal is to enhance patient care and improve health outcomes for veterans with kidney disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans diagnosed with chronic kidney disease who may benefit from ACEI or ARB medications.
Not a fit: Patients who are not veterans or those without chronic kidney disease may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of kidney disease in veterans, potentially reducing the need for dialysis and improving overall survival rates.
How similar studies have performed: Previous research has shown that optimizing medication use in chronic disease management can lead to significant improvements in patient outcomes, suggesting that this approach may be effective.
Where this research is happening
Houston, United States
- Michael E Debakey VA Medical Center — Houston, United States (Active)
Researchers
- Principal investigator: Navaneethan, Sankar Dass — Michael E Debakey VA Medical Center
- Study coordinator: Navaneethan, Sankar Dass
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.